Literature DB >> 24801685

Adiponectin inhibits murine pancreatic cancer growth.

Motohiko Kato1, Kenji Watabe, Masahiko Tsujii, Tohru Funahashi, Iichiro Shimomura, Tetsuo Takehara.   

Abstract

BACKGROUND: Adiponectin is an adipose tissue-derived secretory hormone whose plasma concentrations are lower in obese individuals. Obesity is a risk factor for the development and growth of pancreatic cancer, and hypoadiponectinemia was suggested to be involved in the growth of Pan02 murine pancreatic cancer cells that were inoculated into the flanks of congenitally obese mice. AIM: The aim of this study was to clarify the role of adiponectin in the growth of pancreatic cancer cells.
METHODS: We examined the effect of adiponectin on the growth of Pan02 cells using recombinant adiponectin and adiponectin knockout mice.
RESULTS: The in vitro treatment of Pan02 cells with adiponectin inhibited cellular proliferation that was accompanied by increased apoptosis and caspase-3 and caspase-7 activities. Transplantation of Pan02 cells into the pancreas of knockout mice resulted in a larger tumor volume with fewer terminal deoxyribonucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) positive cells compared with wild-type mice.
CONCLUSIONS: The results indicate that adiponectin directly suppresses the proliferation of Pan02 cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24801685     DOI: 10.1007/s10620-014-3175-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  17 in total

Review 1.  Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms.

Authors:  Paige M Bracci
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

Authors:  K Maeda; K Okubo; I Shimomura; T Funahashi; Y Matsuzawa; K Matsubara
Journal:  Biochem Biophys Res Commun       Date:  1996-04-16       Impact factor: 3.575

3.  The association of circulating adiponectin levels with pancreatic cancer risk: a study within the prospective EPIC cohort.

Authors:  Verena A Grote; Sabine Rohrmann; Laure Dossus; Alexandra Nieters; Jytte Halkjaer; Anne Tjønneland; Kim Overvad; Jakob Stegger; Nathalie Chabbert-Buffet; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Birgit Teucher; Susen Becker; Jukka Montonen; Heiner Boeing; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Domenico Palli; Sabina Sieri; Rosario Tumino; Paolo Vineis; Amalia Mattiello; Marcial Argüelles; Eric J Duell; Esther Molina-Montes; Nerea Larrañaga; María-Dolores Chirlaque; Aurelio Barricarte Gurrea; Suzanne M Jeurnink; Petra Hm Peeters; Weimin Ye; Malin Sund; Björn Lindkvist; Dorthe Johansen; Kay-Tee Khaw; Nick Wareham; Francesca L Crowe; Isabelle Romieu; Sabina Rinaldi; Mazda Jenab; Dora Romaguera; Dominique S Michaud; Elio Riboli; H Bas Bueno-de-Mesquita; Rudolf Kaaks
Journal:  Int J Cancer       Date:  2011-09-17       Impact factor: 7.396

4.  Association of low serum adiponectin levels with erosive esophagitis in men: an analysis of 2405 subjects undergoing physical check-ups.

Authors:  Motohiko Kato; Kenji Watabe; Toshimitsu Hamasaki; Miyuki Umeda; Aiko Furubayashi; Kazuo Kinoshita; Osamu Kishida; Takashi Fujimoto; Akira Yamada; Yoshifumi Tsukamoto; Shunsuke Yamamoto; Yoshihiro Kamada; Yuichi Yoshida; Shinichi Kiso; Shusaku Tsutsui; Shinji Kihara; Norio Hayashi; Yuji Matsuzawa
Journal:  J Gastroenterol       Date:  2011-08-16       Impact factor: 7.527

5.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

6.  Protective role of adiponectin against ethanol-induced gastric injury in mice.

Authors:  Shunsuke Yamamoto; Kenji Watabe; Hiroshi Araki; Yoshihiro Kamada; Motohiko Kato; Takashi Kizu; Shinichi Kiso; Shusaku Tsutsui; Masahiko Tsujii; Shinji Kihara; Tohru Funahashi; Iichiro Shimomura; Norio Hayashi; Tetsuo Takehara
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-02-09       Impact factor: 4.052

7.  Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma.

Authors:  Neeraj K Saxena; Ping P Fu; Arumugam Nagalingam; Jason Wang; Jeffrey Handy; Cynthia Cohen; Mourad Tighiouart; Dipali Sharma; Frank A Anania
Journal:  Gastroenterology       Date:  2010-07-13       Impact factor: 22.682

8.  Pancreatic stellate cells: partners in crime with pancreatic cancer cells.

Authors:  Alain Vonlaufen; Swapna Joshi; Changfa Qu; Phoebe A Phillips; Zhihong Xu; Nicole R Parker; Cheryl S Toi; Romano C Pirola; Jeremy S Wilson; David Goldstein; Minoti V Apte
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

9.  Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer.

Authors:  Martin S Denzel; Lionel W Hebbard; Gregory Shostak; Lawrence Shapiro; Robert D Cardiff; Barbara Ranscht
Journal:  Clin Cancer Res       Date:  2009-05-15       Impact factor: 12.531

10.  Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.

Authors:  Norikazu Maeda; Iichiro Shimomura; Ken Kishida; Hitoshi Nishizawa; Morihiro Matsuda; Hiroyuki Nagaretani; Naoki Furuyama; Hidehiko Kondo; Masahiko Takahashi; Yukio Arita; Ryutaro Komuro; Noriyuki Ouchi; Shinji Kihara; Yoshihiro Tochino; Keiichi Okutomi; Masato Horie; Satoshi Takeda; Toshifumi Aoyama; Tohru Funahashi; Yuji Matsuzawa
Journal:  Nat Med       Date:  2002-06-17       Impact factor: 53.440

View more
  10 in total

Review 1.  Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer.

Authors:  Simone Polvani; Mirko Tarocchi; Sara Tempesti; Lapo Bencini; Andrea Galli
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

2.  Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.

Authors:  Theresa Falls; Dominic Guy Roy; John Cameron Bell; Marie-Claude Bourgeois-Daigneault
Journal:  ILAR J       Date:  2016

Review 3.  Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting.

Authors:  Ramesh Pothuraju; Satyanarayana Rachagani; Wade M Junker; Sanjib Chaudhary; Viswanathan Saraswathi; Sukhwinder Kaur; Surinder K Batra
Journal:  J Exp Clin Cancer Res       Date:  2018-12-19

4.  Adiponectin Suppresses Human Pancreatic Cancer Growth through Attenuating the β-Catenin Signaling Pathway.

Authors:  Jinghui Jiang; Yingchao Fan; Wei Zhang; Yuling Shen; Tingting Liu; Ming Yao; Jianren Gu; Hong Tu; Yu Gan
Journal:  Int J Biol Sci       Date:  2019-01-01       Impact factor: 6.580

Review 5.  Obesity and Pancreatic Cancer: Insight into Mechanisms.

Authors:  Guido Eibl; Enrique Rozengurt
Journal:  Cancers (Basel)       Date:  2021-10-10       Impact factor: 6.639

Review 6.  The Role of Adipokines in Pancreatic Cancer.

Authors:  Qi Wang; Huizhi Wang; Yuntao Ding; Mengtian Wan; Min Xu
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

7.  AdipoRon and Pancreatic Ductal Adenocarcinoma: a future perspective in overcoming chemotherapy-induced resistance?

Authors:  Luigi Sapio; Angela Ragone; Annamaria Spina; Alessia Salzillo; Silvio Naviglio
Journal:  Cancer Drug Resist       Date:  2022-06-21

8.  Adiponectin receptor agonists inhibit leptin induced pSTAT3 and in vivo pancreatic tumor growth.

Authors:  Fanuel Messaggio; Alisha M Mendonsa; Jason Castellanos; Nagaraj S Nagathihalli; Lee Gorden; Nipun B Merchant; Michael N VanSaun
Journal:  Oncotarget       Date:  2017-08-03

9.  Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis.

Authors:  Miho Akimoto; Riruke Maruyama; Yasunari Kawabata; Yoshitsugu Tajima; Keizo Takenaga
Journal:  Cell Death Dis       Date:  2018-07-23       Impact factor: 8.469

10.  Histotripsy Ablation Alters the Tumor Microenvironment and Promotes Immune System Activation in a Subcutaneous Model of Pancreatic Cancer.

Authors:  Alissa Hendricks-Wenger; Jacqueline Sereno; Jessica Gannon; Allison Zeher; Rebecca M Brock; Natalie Beitel-White; Alexander Simon; Rafael V Davalos; Sheryl Coutermarsh-Ott; Eli Vlaisavljevich; Irving Coy Allen
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2021-08-27       Impact factor: 3.267

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.